Emilio
Ros
Emilio Ros
España - Barcelona
Biografía
El Dr. Emilio Ros fue el creador y responsable hasta 2016 de la Unidad de Lípidos, Servicio de Endocrinología y Nutrición, Hospital Clínic, Barcelona. Actualmente es Investigador Emérito del Institut de Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona. Antiguo investigador principal y actualmente miembro de Grupo del CIBEROBN, Instituto de Salud Carlos III, Madrid.
Su formación posgrado transcurrió en EEUU, 1970-1976 (New York y Boston), donde obtuvo el American Board of Internal Medicine y el American Board of Gastroenterology. Fue miembro fundador de la Sociedad Española de Arteriosclerosis (SEA) y fundador y editor de su revista oficial Clínica e Investigación en Arteriosclerosis. Es miembro de la European Atherosclerosis Society (EAS), International Atherosclerosis Society (IAS), American Society of Nutrition y American College of Cardiology. Fue presidente de la Sociedad Iberolatinoamericana de Aterosclerosis (SILAT) 2000-2005.
La contribución científica del Dr. Emilio Ros a los campos de nutrición, lipidología y aterosclerosis ha sido reconocida al ser considerado como parte del 1% de científicos más citados e influyentes del mundo por Clarivate Analytics 2018-2021. Ha publicado en revistas con FI: 530 originales, 95 revisiones y 30 editoriales, además de 90 capítulos de libro (índice h Google Scholar: 113; identificador ORCID 0000-0002-2573-1294). En reconocimiento a su trayectoria científica, ha recibido los premios a la mejor carrera científica en nutrición de la Fundación Danone 2013, SEA 2014 y Centro Catalán de la Nutrición 2015. El Dr. Emilio Ros fue el responsable de la intervención nutricional en el pionero estudio clínico PREDIMED de dieta mediterránea para la prevención primaria cardiovascular.
Su formación posgrado transcurrió en EEUU, 1970-1976 (New York y Boston), donde obtuvo el American Board of Internal Medicine y el American Board of Gastroenterology. Fue miembro fundador de la Sociedad Española de Arteriosclerosis (SEA) y fundador y editor de su revista oficial Clínica e Investigación en Arteriosclerosis. Es miembro de la European Atherosclerosis Society (EAS), International Atherosclerosis Society (IAS), American Society of Nutrition y American College of Cardiology. Fue presidente de la Sociedad Iberolatinoamericana de Aterosclerosis (SILAT) 2000-2005.
La contribución científica del Dr. Emilio Ros a los campos de nutrición, lipidología y aterosclerosis ha sido reconocida al ser considerado como parte del 1% de científicos más citados e influyentes del mundo por Clarivate Analytics 2018-2021. Ha publicado en revistas con FI: 530 originales, 95 revisiones y 30 editoriales, además de 90 capítulos de libro (índice h Google Scholar: 113; identificador ORCID 0000-0002-2573-1294). En reconocimiento a su trayectoria científica, ha recibido los premios a la mejor carrera científica en nutrición de la Fundación Danone 2013, SEA 2014 y Centro Catalán de la Nutrición 2015. El Dr. Emilio Ros fue el responsable de la intervención nutricional en el pionero estudio clínico PREDIMED de dieta mediterránea para la prevención primaria cardiovascular.
Filiaciones
- IDIBAPS (Investigador Emérito)
- CIBEROBN
- Miembro del Nutrition Group, American College of Cardiology
- Miembro del Grupo de Nutrición de la SEA
- Miembro del Comité Científico de la Fundación de Dieta Mediterránea
- Miembro de los Steering Committees de los estudios PREDIMED y PREDIMED-Plus
- CIBEROBN
- Miembro del Nutrition Group, American College of Cardiology
- Miembro del Grupo de Nutrición de la SEA
- Miembro del Comité Científico de la Fundación de Dieta Mediterránea
- Miembro de los Steering Committees de los estudios PREDIMED y PREDIMED-Plus
Áreas de especialización
- Hiperlipidemias genéticas
- Aterosclerosis preclínica (ecografía carotídea y función endotelial)
- Nutrición en la prevención del riesgo cardiovascular y deterioro cognitivo
- Dieta mediterránea
- Frutos secos
- Aterosclerosis preclínica (ecografía carotídea y función endotelial)
- Nutrición en la prevención del riesgo cardiovascular y deterioro cognitivo
- Dieta mediterránea
- Frutos secos
Abstract
Opciones de estilo de vida para prevenir el deterioro cognitivo y la demencia
Lifestyle choices to prevent cognitive decline and dementia
A consequence of population aging is an increased prevalence of age-related disorders, including neurodegenerative diseases, such as Alzheimer disease (AD) and other dementias. Cognitive decline, a harbinger of dementia, and all-type dementia are a leading cause of disability and an increasing challenge to health-care systems worldwide. Recently, anti-amyloid immunotherapy has been approved for early AD, but the clinical benefit of these drugs is modest and treatment has been associated with noticeable safety risks, thus there is a pressing public health need for effective preventive strategies. According to a 2020 report of a Lancet Commission on dementia prevention, there are 12 specific potentially modifiable risk factors for dementia: educational achievement, smoking, physical inactivity, obesity, diabetes, hypertension, alcohol abuse, hearing loss, traumatic brain injury, depression, social isolation, and air pollution.[1] Some of them are intrinsic part of lifestyle and/or may be greatly influenced by its changes, particularly those that are also cardiovascular risk factors. Of note, dietary habits are not even mentioned in the Lancet review, probably because of many uncertainties in spite of much epidemiological research. Over the past decade, systematic reviews by expert panels have concluded that the evidence is generally inadequate to conclude that the risk of cognitive decline and dementia can be modified by the two key lifestyle components diet and physical activity.[2] Healthy, plant-based dietary patterns with proven efficacy against vascular aging, such as the Mediterranean diet, have been examined as exposures for outcomes of cognition/dementia/AD in many long-term prospective studies, with results that tend to be positive in Mediterranean cohorts and null in non-Mediterranean countries. Reasons for these discrepancies may be that in most epidemiologic studies only baseline exposure is considered in spite of many years of follow-up and a critical salutary Mediterranean diet component, such as virgin olive oil, is little consumed outside the Mediterranean area. Randomized trials of the Mediterranean diet or its key foods/nutrients conducted in aged cohorts for outcomes of cognitive function usually have been positive when lasting more than 2 years and, particularly, when targeting populations at risk of cognitive impairment or with memory complaints. Ongoing research continues to enhance our knowledge of the lifestyle factors that promote successful cognitive aging.
Keywords: Cognitive decline, dementia, vascular risk, Mediterranean diet.
Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413–446. Doi: 10.1016/S0140-6736(20)30367-6.
Krivanek TJ, et al. Promoting successful cognitive aging: A ten-year update. J Alzheimer Dis 2021;81:871–920. Doi: 10.3233/JAD-201462.
A consequence of population aging is an increased prevalence of age-related disorders, including neurodegenerative diseases, such as Alzheimer disease (AD) and other dementias. Cognitive decline, a harbinger of dementia, and all-type dementia are a leading cause of disability and an increasing challenge to health-care systems worldwide. Recently, anti-amyloid immunotherapy has been approved for early AD, but the clinical benefit of these drugs is modest and treatment has been associated with noticeable safety risks, thus there is a pressing public health need for effective preventive strategies. According to a 2020 report of a Lancet Commission on dementia prevention, there are 12 specific potentially modifiable risk factors for dementia: educational achievement, smoking, physical inactivity, obesity, diabetes, hypertension, alcohol abuse, hearing loss, traumatic brain injury, depression, social isolation, and air pollution.[1] Some of them are intrinsic part of lifestyle and/or may be greatly influenced by its changes, particularly those that are also cardiovascular risk factors. Of note, dietary habits are not even mentioned in the Lancet review, probably because of many uncertainties in spite of much epidemiological research. Over the past decade, systematic reviews by expert panels have concluded that the evidence is generally inadequate to conclude that the risk of cognitive decline and dementia can be modified by the two key lifestyle components diet and physical activity.[2] Healthy, plant-based dietary patterns with proven efficacy against vascular aging, such as the Mediterranean diet, have been examined as exposures for outcomes of cognition/dementia/AD in many long-term prospective studies, with results that tend to be positive in Mediterranean cohorts and null in non-Mediterranean countries. Reasons for these discrepancies may be that in most epidemiologic studies only baseline exposure is considered in spite of many years of follow-up and a critical salutary Mediterranean diet component, such as virgin olive oil, is little consumed outside the Mediterranean area. Randomized trials of the Mediterranean diet or its key foods/nutrients conducted in aged cohorts for outcomes of cognitive function usually have been positive when lasting more than 2 years and, particularly, when targeting populations at risk of cognitive impairment or with memory complaints. Ongoing research continues to enhance our knowledge of the lifestyle factors that promote successful cognitive aging.
Keywords: Cognitive decline, dementia, vascular risk, Mediterranean diet.
Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413–446. Doi: 10.1016/S0140-6736(20)30367-6.
Krivanek TJ, et al. Promoting successful cognitive aging: A ten-year update. J Alzheimer Dis 2021;81:871–920. Doi: 10.3233/JAD-201462.